Transformational cell therapies for patients with pancreatic disease

OUR PIPELINE OF CELL THERAPIES IS CHANGING THE OUTLOOK FOR PATIENTS WITH CHRONIC PANCREATITIS AND TYPE 1 DIABETES.

VIEW OUR VIDEO TO LEARN ABOUT KOLIGO’S DEDICATION TO THE DEVELOPMENT OF TRANSFORMATIVE CELL THERAPIES.

Koligo Therapeutics, Inc. is a regenerative medicine company dedicated to the commercialization and development of transformative cell therapies for pancreatic diseases. View our video below to learn about Kyslecel™ and our pipeline of other product candidates through the use of 3D bioprinting and other manufacturing advances.

Kyslecel personalized cell therapy for chronic pancreatitis. Because pain should not define your life.